NewsEvents

Your Yourlocation: Home > Clinical efficacy of seretide and tiotropium bromide(136310-93-5) in the treatment of elderly patients with chronic obstructive pulmonary disease

To evaluate the clinical efficacy of sildigrate combined with tiotropium bromide(136310-93-5) in the treatment of chronic obstructive pulmonary disease (COPD). The results showed that the combination of sulidide and tiotropium bromide(136310-93-5) in the treatment of elderly patients with chronic obstructive pulmonary disease (COPD) than the single clinical effect of Seretide treatment was significantly better, with clinical significance, it is worth promoting the use of. The article published on 2014 thirty-fourth issue of "Jilin Medical".

Seventy elderly patients with chronic obstructive pulmonary disease (COPD) were randomly divided into group A (n = 30) and group B (n = 40). Patients in group A were treated with seretide and group B Combined with tiotropium bromide(136310-93-5). The clinical therapeutic effect of the two groups was observed.

The improvement rate of COPD was 43.6% in group A and 87.3% in group B, which was significantly higher than that in group A (P <0.05). The cough, shortness of breath and lungs in group B were significantly higher than those in group B Rales and other clinical symptoms of the improvement should be significantly better than in Group A patients.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved